MYX 2.23% $4.38 mayne pharma group limited

PROJECTED $28 million EBITDA +ve in FY24

  1. 911 Posts.
    lightbulb Created with Sketch. 53
    $14.1m 2HFY23 in line with improvedbusiness performance

    With all 3 business units contributing positive contribution margin, the Company expects to return to positive
    EBITDA and operating cash generation in FY24.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.